ArticlePediatric dermatology2025
Caregiver-Reported Motivation and Access to Mental Health Services for Pediatric Atopic Dermatitis Patients: A Cross-Sectional Study.
Article in Pediatric dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- Pediatric Psychodermatology: Advancing Therapy through Integrated Care.Dermatology and therapy · 2026Review
- Caregiver-Reported Motivation and Access to Mental Health Services for Pediatric Atopic Dermatitis Patients: A Cross-Sectional Study.Pediatric dermatology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Atopic dermatitis (AD) is associated with several comorbidities, including mental health (MH) conditions among children. We conducted a survey study of caregivers of pediatric AD patients (aged 8-17) (n = 163) and collected information about their child's MH symptoms and their experience seeking MH services for their child. Nearly half of caregivers reported their child had 6 or more days of poor MH symptoms in the past month and reported that barriers to accessing MH services were MH provider inaccessibility (27.0%), distance and transportation (23.3%), and insurance obstacles (19.0%). Given the substantial burden of AD on pediatric patients and the accessibility barriers elucidated in this survey study, engagement of both eczema and MH providers is essential to recognize MH burden among patients and overcome access barriers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.